About: Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $18.57 (+1.14%)
NVCT NASDAQ Nuvectis Pharma Inc
Nuvectis Pharma Inc share price
Atividade de preço de NVCT
Último preço
$ 18,570
Variação (24h)
0,21 USD (1,14%)
Volume
117.68K
Volume (média 4 sem.)
-
Abertura
$ 18,61
Variação do dia
$ 18,32 - $ 18,97
Fechamento anterior
$ 18,36
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
NVCT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals